WO2008139264A3 - Formulations de gel mou - Google Patents
Formulations de gel mou Download PDFInfo
- Publication number
- WO2008139264A3 WO2008139264A3 PCT/IB2007/004600 IB2007004600W WO2008139264A3 WO 2008139264 A3 WO2008139264 A3 WO 2008139264A3 IB 2007004600 W IB2007004600 W IB 2007004600W WO 2008139264 A3 WO2008139264 A3 WO 2008139264A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- soft gel
- gel formulations
- formulation
- ubiquinols
- coq
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cette invention porte sur une méthodologie perfectionnée de formulation pour des molécules lipophiles bioactives, telles que la Coenzyme Q10 (CoQ10) et ses analogues réduits (ubiquinols). L'invention porte également sur des procédés de fabrication de capsules de gel mou de cette formulation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002670694A CA2670694A1 (fr) | 2006-11-27 | 2007-11-27 | Formulations de gel mou |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86738906P | 2006-11-27 | 2006-11-27 | |
US60/867,389 | 2006-11-27 | ||
US88621207P | 2007-01-23 | 2007-01-23 | |
US60/886,212 | 2007-01-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008139264A2 WO2008139264A2 (fr) | 2008-11-20 |
WO2008139264A3 true WO2008139264A3 (fr) | 2011-03-03 |
Family
ID=39584306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/004600 WO2008139264A2 (fr) | 2006-11-27 | 2007-11-27 | Formulations de gel mou |
Country Status (3)
Country | Link |
---|---|
US (1) | US20080160077A1 (fr) |
CA (1) | CA2670694A1 (fr) |
WO (1) | WO2008139264A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101677588A (zh) * | 2007-02-01 | 2010-03-24 | 加拿大国家研究委员会 | 亲脂性生物活性分子制剂 |
US20100074963A1 (en) * | 2008-09-23 | 2010-03-25 | Biolife, L.L.C. | Red Palm Oil and Fish Oil Wound Dressing |
AU2009329035A1 (en) * | 2008-12-01 | 2011-06-23 | Laila Pharmaceuticals Pvt. Ltd. | Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof |
US20100215781A1 (en) * | 2009-02-25 | 2010-08-26 | Joar Opheim | Therapeutic composition comprising omega-3 polyunsaturated fatty acid or derivative thereof, resveratrol and green tea |
US8293299B2 (en) | 2009-09-11 | 2012-10-23 | Kraft Foods Global Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids |
CA2797644A1 (fr) * | 2009-12-31 | 2011-07-07 | Edison Pharmaceuticals, Inc. | Traitement du syndrome de leigh et d'un syndrome de type leigh avec des quinones de tocotrienol |
WO2011141935A2 (fr) * | 2010-05-12 | 2011-11-17 | Gujarat Liqui Pharmacaps Pvt. Ltd | Préparation d'artéméther et luméfantrine sous forme de capsule souple et procédé de fabrication correspondant |
US20120156286A1 (en) * | 2010-07-27 | 2012-06-21 | Imagenetix, Inc. | Compositions and methods for increased delivery of coenzyme q10 |
BR112013022044A2 (pt) | 2011-02-28 | 2016-11-29 | Technologies Khlôros Inc | veículo mastigável para absorção na boca |
US9168308B2 (en) * | 2011-04-22 | 2015-10-27 | Paul Joseph FAERSTEIN | Compositions and methods for nutritional supplementation |
CN102488198A (zh) * | 2011-11-18 | 2012-06-13 | 天津天狮生物发展有限公司 | 一种保护心血管系统的抗氧化保健食品制剂及其制备方法 |
US11013248B2 (en) | 2012-05-25 | 2021-05-25 | Kraft Foods Group Brands Llc | Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings |
AU2014285095A1 (en) * | 2013-07-03 | 2016-02-25 | Barrie Tan | CoQ10 (ubiquinone, ubiquinol), vitamin A (retinoic acid, retinol), vitamin E (tocotrienol, tocopherol) and methods of use |
WO2015051448A1 (fr) * | 2013-10-11 | 2015-04-16 | National Research Council Of Canada (Nrc) | Formulation solubilisée de coq10 destinée à être utilisée pour le traitement de la maladie de parkinson |
KR101459070B1 (ko) * | 2013-12-09 | 2014-11-17 | (주) 뉴메딕 | 지속성을 갖는 히알루론산 겔 조성물 |
CN103816093B (zh) * | 2014-03-20 | 2015-12-30 | 宁波亿拍客网络科技有限公司 | —种茶油南瓜护肤膏及加工方法 |
CN107106628B (zh) | 2014-12-22 | 2021-01-12 | 荷兰联合利华有限公司 | 毛发组合物 |
CN106265489A (zh) * | 2016-09-24 | 2017-01-04 | 北京万全德众医药生物技术有限公司 | 一种含氨苯砜的凝胶制剂及其制备方法 |
US11471426B2 (en) | 2019-10-16 | 2022-10-18 | American River Nutrition, Llc | Compositions comprising quinone and/or quinol and methods of preparations and use thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2590810A1 (fr) * | 1992-03-26 | 1993-09-30 | Pharmos Corp. | Systeme de liberation topique et transdermique au moyen de spheres d'huile submicroniques |
CA2436374A1 (fr) * | 2001-02-02 | 2002-08-15 | National Research Council Of Canada | Compositions solubles dans l'eau de composes lipophiles bioactifs |
US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
CA2587677A1 (fr) * | 2004-11-16 | 2006-08-03 | Bioavailability, Inc. | Preparations autoemulsifiantes a concentration elevee a base de coenzyme q10 a usage nutritionnel |
US20060198830A1 (en) * | 2005-03-01 | 2006-09-07 | Siddharth Shastri | Ubiquinone composition and a container for its convenient transport and storage |
-
2007
- 2007-11-27 US US11/946,020 patent/US20080160077A1/en not_active Abandoned
- 2007-11-27 CA CA002670694A patent/CA2670694A1/fr not_active Abandoned
- 2007-11-27 WO PCT/IB2007/004600 patent/WO2008139264A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2590810A1 (fr) * | 1992-03-26 | 1993-09-30 | Pharmos Corp. | Systeme de liberation topique et transdermique au moyen de spheres d'huile submicroniques |
US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
CA2436374A1 (fr) * | 2001-02-02 | 2002-08-15 | National Research Council Of Canada | Compositions solubles dans l'eau de composes lipophiles bioactifs |
CA2587677A1 (fr) * | 2004-11-16 | 2006-08-03 | Bioavailability, Inc. | Preparations autoemulsifiantes a concentration elevee a base de coenzyme q10 a usage nutritionnel |
US20060198830A1 (en) * | 2005-03-01 | 2006-09-07 | Siddharth Shastri | Ubiquinone composition and a container for its convenient transport and storage |
Also Published As
Publication number | Publication date |
---|---|
WO2008139264A2 (fr) | 2008-11-20 |
US20080160077A1 (en) | 2008-07-03 |
CA2670694A1 (fr) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008139264A3 (fr) | Formulations de gel mou | |
HRP20190198T1 (hr) | Formulacije koje stabiliziraju i inhibiraju taloženje imunogenih pripravaka | |
WO2008063910A3 (fr) | Procédé pour préparer des formes de dosage solides de compositions pharmaceutiques à plusieurs phases | |
WO2011017502A3 (fr) | Formulations comprenant du linaclotide | |
PL2280611T3 (pl) | Kompozycje składników aktywnych rozpuszczalnych w tłuszczach, zawierających gumę ghatti | |
HK1107271A1 (en) | Method of enhancing absorptions of transmucosal administration formulations | |
PL1940249T3 (pl) | Nowe formulacje rozpuszczalnych w tłuszczach składników aktywnych o wysokiej biodostępności | |
WO2008064353A3 (fr) | Analogues 4,5-époxy-morphinanium saturé en position 7 et 8 | |
WO2009118107A3 (fr) | Composition d'un produit de soins cutanés | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
WO2007114945A3 (fr) | Compositions et procedes visant a accroitre le statut antioxydant des animals | |
MX2009004862A (es) | Estabilizacion de vacunas por liofilizacion. | |
WO2011048553A3 (fr) | Compositions pharmaceutiques d'inhibiteurs de pde-5 et de dapoxétine | |
PT1810676E (pt) | Formulações de levetiracetam e métodos para a sua preparação | |
IL265947A (en) | Preparation of stansoporfin with a high degree of purification on a large scale | |
WO2004093800A3 (fr) | Derives de thyronamine et analogues et des methodes d'utilisation de ces composes | |
TN2009000510A1 (en) | Extended release formulation of nevirapine | |
WO2009120265A3 (fr) | Compositions et procédés pour la délivrance d’emboliques | |
WO2009140105A3 (fr) | Préparations pour inhibiteurs de la cathepsine k | |
WO2009111428A3 (fr) | Procédés pour synthétiser des glycinols, des glycéollines i et ii, et des compositions d'intermédiaires choisis; et usages thérapeutiques de ceux-ci | |
MXPA06000636A (es) | Formulaciones semi-solidas para la administracion oral de taxoides. | |
WO2014056851A3 (fr) | Formulation (i) d'arôme et de parfum | |
WO2009065130A3 (fr) | Formulations à libération modifiée de diltiazème | |
WO2006138431A3 (fr) | Procedes et preparations pharmaceutiques pour l'accroissement de la biodisponibilite | |
WO2006034495A3 (fr) | Procedes d'utilisation de propyleneglycol-carbonate menthole et ses analogues destines a produire des effets anti-inflammatoires et anti-angiogeniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07874029 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2670694 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07874029 Country of ref document: EP Kind code of ref document: A2 |